Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis

Review of 39 trials (n=6360, 20 drugs and placebo) found dupilumab and cyclosporine may be more effective for up to 16 weeks than methotrexate and azathioprine in adults with atopic dermatitis. More studies comparing established and novel treatments beyond 16 weeks are needed.

Source:

JAMA Dermatology